Gemcitabine-Cisplatin Chemotherapy Induces Nectin-4 Downregulation and Enfortumab Vedotin Resistance in Bladder Cancer. Nossing C, Prantl I, Grausenburger R, Ertl IE, et al. Eur Urol Oncol 2026 Sep 8:S2588-9311(26)00232-4. doi: 10.1016/j.euo.2026.

Read + Share

Amedeo Smart

Independent Medical Education

Nossing C, Prantl I, Grausenburger R, Ertl IE, et al. Gemcitabine-Cisplatin Chemotherapy Induces Nectin-4 Downregulation and Enfortumab Vedotin Resistance in Bladder Cancer. Eur Urol Oncol 2026 Sep 8:S2588-9311(26)00232-4. doi: 10.1016/j.euo.2026.
PMID: 42711240